Semaglutide tends to be a strong fit for patients who: Have a weight loss goal in the 1015% range Have a BMI of 30 or higher, or BMI of 27+ with a related health condition such as elevated blood sugar, high blood pressure, or metabolic dysfunction Have struggled to lose or maintain weight through diet and exercise alone Are not candidates for Tirzepatide due to budget, GI sensitivity, or clinical history Have no personal/family history of medullary thyroid carcinoma or MEN2 syndrome Are not currently pregnant or breastfeeding Semaglutide may not be appropriate with a history of: Pancreatitis MEN syndromes (Multiple Endocrine Neoplasia) GERD or significant acid reflux Severe constipation or GI motility disorders A previous adverse reaction to semaglutide or GLP-1 medications Active GI conditions that may be worsened by slowed gastric emptying What is Semaglutide
The semaglutide dosage calculator can help men understand the differences in dosing between the two medications
One patient had LGE in the midmyocardium in the basal inferolateral segments, and the other patient had LGE in the midmyocardium in the lateral midventricular segment
Everybody responds differently, but most patients notice visible improvements within 8 to 12 weeks of starting treatment
SLE is a chronic autoimmune condition that affects around 1 in 1,000 people in the UK and is around six times more common in women than men
Side effects: Common side effects of Wegovy include nausea, vomiting, diarrhea, constipation, and stomach pain
